|
|
Volumn 14, Issue 1, 2008, Pages 10-
|
|
From the guest editor
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANDROGEN;
DOCETAXEL;
PROSTATE SPECIFIC ANTIGEN;
VITAMIN D DERIVATIVE;
ANDROGEN RECEPTOR;
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
EDITORIAL;
METASTASIS;
PRIORITY JOURNAL;
PROSTATE CANCER;
RECURRENT CANCER;
UNITED STATES;
DISEASE COURSE;
DRUG EFFECT;
HUMAN;
MALE;
METABOLISM;
PROSTATE TUMOR;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS;
DISEASE PROGRESSION;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
RECEPTORS, ANDROGEN;
|
|
EID: 67649962979
PISSN: 15289117
EISSN: 1540336X
Source Type: Journal
DOI: 10.1097/PPO.0b013e318164060a Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
